Head and neck cancer organoids as a promising tool for personalized cancer therapy: A literature review.

Nooshin MohtashamFarnaz Mohajer TehranHamid Abbaszadeh

Published in: Health science reports (2022)

Since HNC-derived organoids seem to recapitulate characteristics of original tumors and to show differential responses to different chemotherapy and targeted therapy agents, these organoids might have the potential to be used as preclinical prediction tools for the treatment of HNC patients.

Keyphrases

cancer therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes
radiation therapy
mesenchymal stem cells
replacement therapy